<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11398">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02958553</url>
  </required_header>
  <id_info>
    <org_study_id>P16-01</org_study_id>
    <nct_id>NCT02958553</nct_id>
  </id_info>
  <brief_title>EmPOWERing Active Seniors With Energy</brief_title>
  <acronym>EASE</acronym>
  <official_title>EmPOWERing Active Seniors With Energy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BionX Medical Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BionX Medical Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study comparing the emPOWER Ankle System to standard carbon fiber prosthetic feet, in
      active seniors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to show increased mobility and improvement in balance
      and other activities of daily living with the emPOWER Ankle, a powered prosthesis, compared
      to standard carbon fiber prosthetic feet, in active seniors.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Six Minute Walk Test</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment</time_frame>
    <description>The primary endpoint of this trial will be an improvement in walking distance with the emPOWER Ankle over the distance covered with the subject's passive prosthesis as shown by 6MWT results.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ramp Test</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment</time_frame>
    <description>Timed performance test of walking up and down an ADA compliant ramp 3 times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic Limb Users Survey of Mobility PLUS-M (12 item Short Form)</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment and at 3, 6 and 12 months</time_frame>
    <description>Survey Instrument: Prosthetic Limb Users Survey of Mobility PLUS-M (12 item Short Form)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities-specific Balance Confidence Scale</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment</time_frame>
    <description>Survey Instrument: Activities-specific Balance Confidence Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Physical Function</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment and at 3, 6 and 12 months</time_frame>
    <description>Survey Instrument: PROMIS Physical Function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Global Health Short Form</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment and at 3, 6 and 12 months</time_frame>
    <description>Survey Instrument: PROMIS Global Health Short Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Fatigue Short Form (7a)</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment and at 3, 6 and 12 months</time_frame>
    <description>Survey Instrument: PROMIS Fatigue Short Form (7a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Pain Intensity Short Form (3a)</measure>
    <time_frame>2nd and 3rd study visits which will take place within 45 days of enrollment and at 3, 6 and 12 months</time_frame>
    <description>Survey Instrument: PROMIS Pain Intensity Short Form (3a)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Falls</measure>
    <time_frame>3rd study visit which will take place within 45 days of enrollment</time_frame>
    <description>Self-Report Diary: Falls</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Amputation</condition>
  <arm_group>
    <arm_group_label>Subject's Passive Prosthesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subject's own passive prosthesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>emPOWER Ankle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>emPOWER Ankle (powered prosthesis)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>emPOWER Ankle</intervention_name>
    <description>The device is 510k cleared and is intended to replace a missing foot and ankle. The emPOWER Ankle is to be used exclusively for fittings of lower-extremity amputations as prescribed by a healthcare professional.</description>
    <arm_group_label>Subject's Passive Prosthesis</arm_group_label>
    <arm_group_label>emPOWER Ankle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females

          -  62 years or older

          -  Subjects with transtibial amputations of either leg at least 1 year prior

          -  Socket Comfort Score of at least 6

          -  Sock fluctuation of â‰¤ 8 ply per day

          -  K-level rating of 3 or 4 based on the Amputee Mobility Predictor Assessment Tool

          -  Ability to walk at a walking speed of &gt; 0.75 meters per second

          -  Unilateral amputees (up to 7 bilateral amputees can be included, 1 per site in
             addition to the unilateral amputees who will be analyzed as a separate sub group)

          -  Foot size: 25-30 cm

          -  Ability to complete a continuous 6-Minute Walk Test

          -  Ability to provide written, informed consent

          -  Ability to complete study visits and study documents

          -  Ability to manage the complexity of a powered device including charging and changing
             batteries as needed

          -  Ability to read and understand English

        Exclusion Criteria:

          -  Subjects who have never used a prosthetic device

          -  Less than 62 years of age

          -  Weight &lt;150 lbs. or &gt; 287 lbs.

          -  Transfemoral amputees

          -  Active sores or ulceration on subject's residual limb

          -  Sore on contralateral foot.

          -  Cuff-link socket suspension

          -  Socket Comfort Score less than 6

          -  Sock fluctuation of &gt; 8 per day

          -  K level of 1 or 2

          -  Amputation clearance &lt; 8.625&quot;

          -  History of stroke or TIA that impairs current walking

          -  Recent history of excessive falling defined as more than 2 falls requiring medical
             assistance in the prior year

          -  Medications potentially affecting balance

          -  Recent hospitalization (within past 3 months)

          -  Cognitive deficiency that would impact ability to charge and change batteries as
             needed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>62 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danielle Melton, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katy Bonnin</last_name>
    <phone>(781)761-1516</phone>
    <email>kbonnin@bionxmed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Northwestern University Prosthetics-Orthotics Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Gard, PhD</last_name>
      <phone>312-503-5718</phone>
      <email>sgard@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Gard, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Omaha, Biomechanics Research</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68182</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kota Takahashi, PhD</last_name>
      <phone>402-554-4184</phone>
      <email>ktakahashi@unomaha.edu</email>
    </contact>
    <investigator>
      <last_name>Kota Takahashi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oregon, Bowerman Sports Science Clinic</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Hahn, PhD</last_name>
      <phone>541-346-3554</phone>
      <email>mhahn@uoregon.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Hahn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UTHealth, Department of Orthopedic Surgery</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kacee E Pavelka</last_name>
      <phone>713-797-5926</phone>
      <email>kacee.e.pavelka@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Danielle Melton, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 27, 2016</lastchanged_date>
  <firstreceived_date>November 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lower Extremity Limb Loss</keyword>
  <keyword>Prosthesis Use</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
